PER 2.41% 8.1¢ percheron therapeutics limited

Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-22

  1. 89 Posts.
    lightbulb Created with Sketch. 43
    R&D rebates are 50% of the total cost.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.